Bendamustine-induced nephrogenic diabetes insipidus – A case report
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Oncology Pharmacy Practice"
DOI: 10.1177/10781552211013878
Abstract: Introduction In patients with relapsed or refractory lymphoma, high-dose chemoimmunotherapy with subsequent autologous hematopoietic cell transplantation (HCT) is a standard of care. Bendamustine, an alkylating agent, is used in the BeEAM (bendamustine, etoposide, cytarabine, melphalan)… read more here.
Keywords: diabetes insipidus; case report; bendamustine; bendamustine induced ... See more keywords